İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

AHMET ACAR

DOÇENT

ORTA DOĞU TEKNİK ÜNİVERSİTESİ FEN-EDEBİYAT FAKÜLTESİ BİYOLOJİK BİLİMLER BÖLÜMÜ

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 30
  • Proje 0
  • Kitap 2
  • Bildiri 6
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 24 Q2 2 Q3 1 Q4 1
WoS (JCR) Q1 18 Q2 9 Q3 0 Q4 1
TR Index 1 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 30 yayın

Scopus (SJR)
Q1 24 Q2 2 Q3 1 Q4 1
WoS (JCR)
Q1 18 Q2 9 Q3 0 Q4 1
TR Index
1 makale

Makale listesi

  1. 2025 Endoglin mediates the tumor- and metastasis-promoting traits of stromal myofibroblasts in human breast carcinomas MOLECULAR ONCOLOGY DOI 10.1002/1878-0261.70074 YÖKSİS SJR Q1 JCR Q2
  2. 2025 Colorectal cancer tumor grade segmentation: A new dataset and baseline results Heliyon DOI 10.1016/j.heliyon.2025.e42467 YÖKSİS SJR Q1 JCR Q1
  3. 2025 Benchmarking long-read structural variant calling tools and combinations for detecting somatic variants in cancer genomes SCIENTIFIC REPORTS DOI 10.1038/s41598-025-92750-x YÖKSİS SJR Q1 JCR Q1
  4. 2025 A Roadmap for the Future of Systems Biology in Cancer Research CANCER RESEARCH DOI 10.1158/0008-5472.CAN-25-0700 YÖKSİS SJR Q1 JCR Q1
  5. 2025 Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm CANCER RESEARCH DOI 10.1158/0008-5472.CAN-25-0999 YÖKSİS SJR Q1 JCR Q1
  6. 2025 Phenotypic plasticity including drug efflux drives reversible irinotecan resistance in LIM1215 colorectal cancer cells FEBS LETTERS DOI 10.1002/1873-3468.70208 YÖKSİS SJR Q1 JCR Q2
  7. 2025 Investigation of potential KRASG12D inhibitors: a comparative study between MRTX1133 and natural compounds via computational structural biology approaches BMC RESEARCH NOTES DOI 10.1186/s13104-025-07137-y YÖKSİS SJR Q3 JCR Q2
  8. 2024 Characterization of dabrafenib-induced drug insensitivity via cellular barcoding and collateral sensitivity to second-line therapeutics Scientific Reports DOI 10.1038/s41598-023-50443-3 YÖKSİS SJR Q1 JCR Q1
  9. 2024 Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy Frontiers in Cell and Developmental Biology DOI 10.3389/fcell.2024.1369597 YÖKSİS SJR Q1 JCR Q1
  10. 2024 Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach Biomedicines DOI 10.3390/biomedicines12010217 YÖKSİS SJR Q1 JCR Q1
  11. 2024 Exploiting Matrix Stiffness to Overcome Drug Resistance ACS Biomaterials Science & Engineering DOI 10.1021/acsbiomaterials.4c00445 YÖKSİS SJR Q1 JCR Q2
  12. 2024 Covalent docking-based virtual screening and molecular dynamics simulations identify C02b as a potential KRAS(G12C) inhibitor Tumor Discovery DOI 10.36922/td.5163 YÖKSİS
  13. 2024 Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer Nature Cancer DOI 10.1038/s43018-024-00787-0 YÖKSİS SJR Q1 JCR Q1
  14. 2023 Pan-Cancer Analysis of the COVID-19 Causal Gene SLC6A20 ACS Omega DOI 10.1021/acsomega.3c00407 YÖKSİS SJR Q2 JCR Q2
  15. 2023 Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors NATURE GENETICS DOI 10.1038/s41588-023-01313-1 YÖKSİS SJR Q1 JCR Q1
  16. 2023 Editorial: Cancer evolution Frontiers in Genetics DOI 10.3389/fgene.2023.1187687 YÖKSİS SJR Q2 JCR Q2
  17. 2023 Investigation of evolutionary dynamics for drug resistance in 3D spheroid model system using cellular barcoding technology PLoS One DOI 10.1371/journal.pone.0291942 YÖKSİS SJR Q1 JCR Q1
  18. 2023 Identification of collateral sensitivity and evolutionary landscape of chemotherapy-induced drug resistance using cellular barcoding technology Frontiers in Pharmacology DOI 10.3389/fphar.2023.1178489 YÖKSİS SJR Q1 JCR Q1
  19. 2023 Integrative profiling of CEACAM1 in different malignancies with implications on the SARS-CoV-2 infection genes ACE2 and TMPRSS2 Hacettepe University DOI 10.15671/hjbc.1232843 YÖKSİS TR Index
  20. 2022 Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancers Scientific Reports DOI 10.1038/s41598-022-15911-2 YÖKSİS SJR Q1 JCR Q2

Akademisyenlere dön